LabXchange’s Post

*Hello Monday: Embrace Diversity of Thought* As we step into a new week, let's embrace the diversity of thought that enriches our lives, much like the varied branches of scientific knowledge. Each day presents an opportunity to explore new ideas, challenge our perspectives, and contribute to a collective understanding that drives innovation and growth. At Helix Biogen Institute, we believe in the power of diverse thinking. Our commitment to fostering a collaborative environment where unique ideas flourish is at the heart of our scientific endeavors. This week, we encourage you to approach your tasks with an open mind and a willingness to learn from the myriad of perspectives around you. Remember, it is through the fusion of different viewpoints that we can achieve breakthroughs and advance our knowledge. Let's make this week a testament to the strength found in diversity and the endless possibilities it brings. Wishing you a productive and insightful week ahead! Dr. Oladipo Elijah Kolawole (Ph.D) Helix Biogen Institute #HelloMonday #DiversityOfThought #ScientificKnowledge #Innovation #HelixBiogenInstitute #CollaborativeEnvironment #NewWeekNewIdeas

It's been a week since the ELRIG UK Drug Discovery conference, and what an event! Reflecting on the insightful discussions, I left with a renewed sense of excitement for the future of our industry. Despite post pandemic turbulence, the conference highlighted the resilience and innovation driving us forward. ⁣ ⁣ 𝐌𝐲 𝐤𝐞𝐲 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬:⁣ ⁣ *𝐈𝐧𝐭𝐞𝐫𝐝𝐢𝐬𝐜𝐢𝐩𝐥𝐢𝐧𝐚𝐫𝐲 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐤𝐞𝐲: the most groundbreaking ideas come when we break down silos. Observing cross-industry partnerships flourish reinforced the power of collaboration in solving the most complex challenges.⁣ ⁣ *𝐇𝐚𝐫𝐧𝐞𝐬𝐬𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 & 𝐀𝐈: From automation to AI-powered platforms, its evident that the future of drug discovery lies in advanced technologies. Great to hear about real-world examples of AI transforming research speed and accuracy, making processes faster and scalable. ⁣ *𝐏𝐚𝐭𝐢𝐞𝐧𝐭-𝐂𝐞𝐧𝐭𝐞𝐫𝐞𝐝 𝐅𝐨𝐜𝐮𝐬: At the end of the day, it's all about improving lives. Every session, from early discovery to translational medicine, was a reminder that patients are at the heart of what we do.⁣ ⁣ *𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 & 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲: Elrig's commitment to sustainability and fostering diversity stood out. Their push for an inclusive and accessible community reflects their vision of an equitable future in life sciences. #elrigdd24 #reflections #drugdiscovery #srgtalent #AI #diversity #collaboration

🚀 𝙀𝙭𝙘𝙞𝙩𝙞𝙣𝙜 𝙋𝙖𝙣𝙚𝙡 𝘼𝙡𝙚𝙧𝙩! 🚀 We are thrilled to announce our interactive panel at the 25th Drug Discovery Innovation Programme (𝗗𝗗𝗜𝗣2025), titled "𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁: 𝗖𝗿𝗼𝘀𝘀-𝗗𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗮𝗿𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀." 🌟 📅 𝗗𝗮𝘁𝗲: March 4-5, 2025 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: San Diego, USA In this dynamic session, we’ll explore how the convergence of innovation and investment is transforming the life sciences landscape. Join industry leaders, investors, and pioneers as we delve into: 🔬 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀: Discover cutting-edge approaches and technologies driving advancements in drug discovery and development. 💡 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗧𝗿𝗲𝗻𝗱𝘀: Gain insights into emerging trends and opportunities for investment in life sciences, and how they are shaping the future of healthcare. 🌐 𝗖𝗿𝗼𝘀𝘀-𝗗𝗶𝘀𝗰𝗶𝗽𝗹𝗶𝗻𝗮𝗿𝘆 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: Learn from experts across various fields about the power of interdisciplinary collaboration in overcoming challenges and fostering breakthroughs. 🎙️ 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻𝘀: Engage with panelists through live Q&A sessions and interactive discussions, sharing your perspectives and gaining valuable knowledge. Don't miss this opportunity to bridge the gap between innovation and investment and gain a deeper understanding of the forces shaping the future of life sciences. 𝗦𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁 𝘁𝗼𝗱𝗮𝘆 and be part of the conversation that’s driving the next wave of discovery and development! 🌍 af@worldbigroup.com #DDIP2025 #LifeSciences #Innovation #Investment #DrugDiscovery #PanelDiscussion #CrossDisciplinaryInsights

𝐀𝐭𝐭𝐞𝐧𝐝𝐢𝐧𝐠 𝐁𝐢𝐨𝐓𝐞𝐜𝐡𝐗 𝐔𝐒𝐀 𝐢𝐧 𝐏𝐡𝐢𝐥𝐚𝐝𝐞𝐥𝐩𝐡𝐢𝐚? Meet our leaders 𝐃𝐞𝐞𝐩𝐭𝐢 𝐓𝐚𝐲𝐚𝐥, 𝐏𝐡𝐃, and 𝐀𝐣𝐢𝐧𝐤𝐲𝐚 𝐒𝐚𝐬𝐞, 𝐏𝐡.𝐃., to explore how InsiMine's tailored, data-driven solutions can drive your biotech innovations forward. Discover insights and strategies that deliver real impact. #BioTechXUSA #insimine

𝐈𝐧𝐬𝐢𝐌𝐢𝐧𝐞 𝐚𝐭 𝐁𝐢𝐨𝐓𝐞𝐜𝐡𝐗!   Stop by InsiMine booth #S13 today and tomorrow at BioTechX USA in Philadelphia to understand how we can support pharma and biotech companies in strategically elevating their business operations through AI-driven, informed decision-making.   Looking forward to connecting with the attendees!   #BioTechXUSA2024 #generativeAI #healthcareAI

🤔 What are the new frontiers in #TechBio? How do we see the intersection of biology and tech evolving?   This Wednesday was the launch of a new HTBC TechBio chapter led by Leigh Brody, AlbionVC life sciences investor. TechBio Club is a breakfast session that welcomes founders, operators, and investors for a quarterly deepdive on the state of the TechBio ecosystem.   Thank you to our stellar first panel: Javier Nunez-Vicandi, Sofinnova Partners, Paul Ashley, Johnson & Johnson, Ian McKay, Innovate UK Leigh Brody, AlbionVC (Moderator) Key take-aways from the discussion include: 🖖 There remains a gap in the investment landscape - techbio companies require investors with understanding both tech and bio 👨💻 The growth of techbio has been in part thanks to AI within the life science sector, but challenges around genetic data, regulatory hurdles, ethical considerations and incorporation into clinical practice are just a few of the hurdles 🌍 It's expected that there will be a streamlining of aids targeting 'low-hanging' problems soon, highlighting the dynamic nature of the field and the ongoing quest for innovation Many thanks to HSBC Innovation Banking for hosting this quarter's session at their offices and supporting this event. If you are operating in the space and would like to join the next session, register your interest here: https://lnkd.in/e_bW72gw #healthcare #techbio #digitalhealth #deeptech #lifesciences #ai #drugdiscovery #vc #founders #operators #experts #investors #venturecapital #community

*Hello Monday: Embrace Diversity of Thought* As we step into a new week, let's embrace the diversity of thought that enriches our lives, much like the varied branches of scientific knowledge. Each day presents an opportunity to explore new ideas, challenge our perspectives, and contribute to a collective understanding that drives innovation and growth. At Helix Biogen Institute, we believe in the power of diverse thinking. Our commitment to fostering a collaborative environment where unique ideas flourish is at the heart of our scientific endeavors. This week, we encourage you to approach your tasks with an open mind and a willingness to learn from the myriad of perspectives around you. Remember, it is through the fusion of different viewpoints that we can achieve breakthroughs and advance our knowledge. Let's make this week a testament to the strength found in diversity and the endless possibilities it brings. Wishing you a productive and insightful week ahead! Dr. Oladipo Elijah Kolawole (Ph.D) Helix Biogen Institute #HelloMonday #DiversityOfThought #ScientificKnowledge #Innovation #HelixBiogenInstitute #CollaborativeEnvironment #NewWeekNewIdeas

🌍🔬 Happy Global Biotech Week!🔬🌍 As we celebrate Global Biotech Week, we are reflecting on how biotechnology continues to shape the future of healthcare, innovation, and research across the globe. From improving patient outcomes to driving forward groundbreaking advancements in medical devices, this field is constantly evolving—and DIA Labs is proud to be part of this journey. At DIA Labs, we are committed to pushing the boundaries of what’s possible in healthcare technology. Our latest work with **AirSense**, an innovative asthma monitoring device, is just one of the many ways we’re striving to make a meaningful impact. By working alongside healthcare providers, researchers, and thought leaders in the biotechnology space, we are aiming to deliver life-changing solutions to patients around the world. This week, let’s celebrate the incredible talent, innovation, and collaboration that defines the biotech industry. Here’s to creating a healthier, more sustainable future for all! #GlobalBiotechWeek #InnovationInHealthcare #Biotechnology #DIALabs #MedicalDevices #AsthmaResearch #HealthcareTech #ClinicalResearch

Excited to participate in the second annual BioCentury & BIA CEO and Investor Dialogue on the sidelines of the 2024 #Jefferies Healthcare conference in London next week. If you’ve navigated through the toughest downturn in #biotech history, you’ve proven your mettle. But the challenges for CEOs and boards will only grow in 2025. Delivering results in an uncertain market is the name of the game.➤ How do you ensure discipline and advance your pipeline to the next inflection point? ➤ How do you experiment with AI and data science to accelerate drug development? ➤ How do you differentiate yourself from peers to find the right investors, partners, and talent?BioCentury Inc. and BioIndustry Association (BIA) convene a special industry roundtable at the 2nd annual CEO and investor dialogue to answer these questions and more.Panelists: ➤ Laura Lane, Eli Lilly & Co ➤ Michael Margolis, Oppenheimer & Co. ➤ Evan Matlin, MTS Health Partners ➤ Chris Sheldon, GlaxoSmithKline ➤ Erica Whittaker, UCB VenturesModerator: Stephen Hansen, BioCenturyView the agenda and register to join us during #LondonLifeSciencesWeek: https://lnkd.in/ecMG7-ZZ you are a BioCentury subscriber or BIA member, please email conferences@biocentury.com for a registration code to access exclusive member/subscriber pricing.#LLSW2024 #BiotechCommunity #LifeSciences #LondonLifeSciences

FogPharma CEO Mathai Mammen, M.D., Ph.D., will be at the rEVOLUTION Symposium this week in Washington, DC, to moderate a panel on the inevitability and utility of AI in the development of therapies for patients. The rEVOLUTION meeting is held every 1-2 years in DC, and brings together thought leaders to tackle some of R&D’s most significant challenges. The location also allows significant participation by DC’s policymakers and regulators.   Joining Mathai for this important discussion will be Nicolle Gatto, Ph.D., Chief Scientific Officer at Aetion; Najat Khan, PhD, Former Chief Data Science Officer & Global Head, Strategy & Portfolio, R&D at Johnson & Johnson; Eric Schadt, Ph.D., Chief Scientific Officer at Pathos; and other leaders.    AI, and data science broadly, are technologies we’re passionate about at FogPharma. Today, a lot of attention is being paid to the role of data science in drug discovery, but in fact some of the biggest gains in the near term will be made in drug development. Numerous resource-intensive, strategically critical drug development challenges — including clinical site selection, patient recruitment, protocol design, endpoint definition, responder and non-responder signatures, and synthetic control arms — will be revolutionized by data science in the coming years.   At Fog, we hope to combine experimental science and these sorts of data science advances to revolutionize the discovery and development of transformational medicines.    Explore the rEVOLUTION event agenda here:  https://bit.ly/44jUIoH   #drugdiscovery #artificialIntelligence #datascience #oncology